Submitted by Anonymous (not verified) on 1 September 2026 - 14:44
Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 4, Status: Authorised
Source:
